A combined Single and Multiple Rising Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of SCH900062 in Healthy Adult Volunteers

A combined Single and Multiple Rising Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of SCH900062 in Healthy Adult Volunteers - SCH900062 FIH study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32905

Enrollment

Registered

2009-12-15

Start date

2009-12-30

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease cognitive dysfunction

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Males and females Between 30-60 years of age

Exclusion criteria

Exclusion criteria: Clinical significant abnormalities for medical examination

Design outcomes

Primary

Measure	Time frame
Safety and tolerability	—

Secondary

Measure	Time frame
Pharmacokinetics, bioavailability	—

Countries

Netherlands

Outcome results